MRI in multiple sclerosis: current status and future prospects

The Lancet Neurology

Volumn 7, Issue 7, 2008, Pages 615-625

  Bakshi, Rohit ^a   Thompson, Alan J ^b   Rocca, Maria A ^c   Pelletier, Daniel ^d   Dousset, Vincent ^e   Barkhof, Frederik ^f   Inglese, Matilde ^g   Guttmann, Charles RG ^a   Horsfield, Mark A ^h   Filippi, Massimo ^c  

^a Center for Neurological Imaging Partners Multiple Sclerosis Center   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

BRAIN ATROPHY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MULTIPLE SCLEROSIS; MYELIN SHEATH; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIODIAGNOSIS; REVIEW; SPINAL CORD;

BRAIN MAPPING; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 50049104744     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(08)70137-6     Document Type: Review

References (98)

1. Polman C., Reingold S., Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58 (2005) 840-846
2. Charil A., Yousry T., Rovaris M., et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol 5 (2006) 841-852
3. McDonald W., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50 (2001) 121-127
4. Dalton C., Brex P., Miszkiel K., et al. New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. Ann Neurol 53 (2003) 673-676
5. Tintore M., Rovira A., Rio J., et al. New diagnostic criteria for multiple sclerosis. Application in first demyelinating episode. Neurology 60 (2003) 27-30
6. Swanton J., Fernando K., Dalton C., et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiat 77 (2006) 830-833
7. Swanton J., Rovira A., Tintore M., et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a retrospective study. Lancet Neurol 6 (2007) 677-686
8. Wattjes M., Harzheim M., Kuhl C., et al. Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic MR imaging criteria for multiple sclerosis?. AJNR Am J Neuroradiol 27 (2006) 1794-1798
9. Thompson A., Montalban X., Barkhof F., et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47 (2000) 831-835
10. Lassmann H., Brück W., and Lucchinetti C. The immunopathology of multiple sclerosis: an overview. Brain Pathol 17 (2007) 210-218
11. Neema M., Stankiewicz J., Arora A., Guss Z., and Bakshi R. MRI in multiple sclerosis: what's inside the toolbox?. Neurotherapeutics 4 (2007) 602-617
12. Pirko I., Lucchinetti C., Sriram S., and Bakshi R. Gray matter involvement in multiple sclerosis. Neurology 68 (2007) 634-642
13. Miller D., Thompson A., and Filippi M. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol 250 (2003) 1407-1419
14. Meier D., Weiner H., and Guttmann C. MR imaging intensity modeling of damage and repair in multiple sclerosis: relationship of short-term lesion recovery to progression and disability. AJNR Am J Neuroradiol 28 (2007) 1956-1963
15. Duan Y., Hildenbrand P., Sampat M., et al. Segmentation of subtraction images for measurement of lesion change in multiple sclerosis. AJNR Am J Neuroradiol 29 (2008) 340-346
16. Bermel R., and Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 5 (2006) 158-170
17. Lazeron R., de Sonneville L., Scheltens P., Polman C., and Barkhof F. Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction. Mult Scler 12 (2006) 760-768
18. Prinster A., Quarantelli M., Orefice G., et al. Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. NeuroImage 29 (2006) 859-867
19. Morgen K., Sammer G., Courtney S., et al. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. NeuroImage 30 (2006) 891-898
20. Nucifora P., Verma R., Lee S., and Melhem E. Diffusion-tensor MR imaging and tractography: exploring brain microstructure and connectivity. Radiology 245 (2007) 367-384
21. Carone D., Benedict R., Dwyer M., et al. Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS. NeuroImage 29 (2006) 505-514
22. Sicotte N., Kern K., Giesser B., et al. Regional hippocampal atrophy in multiple sclerosis. Brain 131 (2008) 1134-1141
23. Rudick R. Impact of disease-modifying therapies on brain and spinal cord atrophy in multiple sclerosis. J Neuroimaging 14 (2004) 54S-64S
24. Miller D., Soon D., Fernando K., et al. MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. Neurology 68 (2007) 1390-1401
25. Chen J., Collins D., Atkins H., et al. Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis. Neurology 66 (2006) 1935-1937
26. Jasperse B., Minneboo A., de Groot V., et al. Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis. Arch Neurol 64 (2007) 190-194
27. Kalkers N., Vrenken H., Uitdehaag B., Polman C., and Barkhof F. Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue. Mult Scler 8 (2002) 410-414
28. Bermel R., Puli S., Rudick R., et al. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol 62 (2005) 1371-1376
29. Dousset V., Brochet B., Deloire M., et al. MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. AJNR Am J Neuroradiol 27 (2006) 1000-1005
30. Vellinga M., Oude Engberink R., Seewann A., et al. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain 131 (2008) 800-807
31. Strijkers G., Mulder W., van Tilborg G., and Nicolay K. MRI contrast agents: current status and future perspectives. Anticancer Agents Med Chem 7 (2007) 291-305
32. Chen J., Sans M., Bogdanov Jr. A., and Weissleder R. Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. Radiology 240 (2006) 473-481
33. Wessig C., Bendszus M., and Stoll G. In vivo visualization of focal demyelination in peripheral nerves by gadofluorine M-enhanced magnetic resonance imaging. Exp Neurol 204 (2007) 14-19
34. Helms G. Volume correction for edema in single-volume proton MR spectroscopy of contrast-enhancing multiple sclerosis lesions. Magn Reson Med 46 (2001) 256-263
35. Srinivasan R., Sailasuta N., Hurd R., Nelson S., and Pelletier D. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 128 (2005) 1016-1025
36. De Stefano N., Filippi M., Miller D., et al. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology 69 (2007) 1942-1952
37. Mader I., Seeger U., Weissert R., et al. Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis. Brain 124 (2001) 953-961
38. 13C-1-pyruvate. Magn Reson Med 58 (2007) 65-69
39. Wolff S., and Balaban R. Magnetization transfer imaging: practical aspects and clinical applications. Radiology 192 (1994) 593-599
40. van Waesberghe J., Kamphorst W., De Groot C., et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46 (1999) 747-754
41. Schmierer K., Scaravilli F., Altmann D., Barker G., and Miller D. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 56 (2004) 407-415
42. Filippi M., and Rocca M. Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve. Neurotherapeutics 4 (2007) 401-413
43. Filippi M., Iannucci G., Tortorella C., et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 52 (1999) 588-594
44. Ge Y., Grossman R., Udupa J., Babb J., Mannon L., and McGowan J. Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis. J Comput Assist Tomogr 26 (2002) 62-68
45. Horsfield M., Barker G., Barkhof F., Miller D., Thompson A., and Filippi M. Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis. J Magn Reson Imaging 17 (2003) 389-397
46. Chen J., Kuhlmann T., Jansen G., et al. Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion. NeuroImage 36 (2007) 1152-1158
47. Chen J., Collins D., Freedman M., Atkins H., Arnold D., and Canadian MS/BMT Study Group. Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients. NeuroImage 25 (2005) 1272-1278
48. Sled J., and Pike G. Quantitative interpretation of magnetization transfer in spoiled gradient echo MRI sequences. J Magn Reson 145 (2000) 24-36
49. 1H fraction in tissues. Magn Reson Med 49 (2003) 864-871
50. Tozer D., Ramani A., Barker G., Davies G., Miller D., and Tofts P. Quantitative magnetization transfer mapping of bound protons in multiple sclerosis. Magn Reson Med 50 (2003) 83-91
51. Narayanan S., Francis S., Sled J., et al. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter. NeuroImage 29 (2006) 637-642
52. Behrens T., Johansen-Berg H., Woolrich M., et al. Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci 6 (2003) 750-757
53. Audoin B., Guye M., Reuter F., et al. Structure of WM bundles constituting the working memory system in early multiple sclerosis: a quantitative DTI tractography study. NeuroImage 36 (2007) 1324-1330
54. Pagani E., Filippi M., Rocca M., and Horsfield M. A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis. NeuroImage 26 (2005) 258-265
55. Jbabdi S., Woolrich M., Andersson J., and Behrens T. A Bayesian framework for global tractography. NeuroImage 37 (2007) 116-129
56. Kamada K., Houkin K., Takeuchi F., et al. Visualization of the eloquent motor system by integration of MEG, functional, and anisotropic diffusion-weighted MRI in functional neuronavigation. Surg Neurol 59 (2003) 353-362
57. Bodurka J., and Bandettini P. Toward direct mapping of neuronal activity: MRI detection of ultraweak, transient magnetic fields changes. Magn Reson Med 47 (2002) 1052-1058
58. Truong T., and Song A. Finding neuroelectric activity under magnetic-field oscillations (NAMO) with magnetic resonance imaging in vivo. Proc Natl Acad Sci U S A 103 (2006) 12598-12601
59. Ogawa S., Lee T., Kay A., and Tank D. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 87 (1990) 9868-9872
60. Rocca M., and Filippi M. Functional MRI in multiple sclerosis. J Neuroimaging 1 (2007) 36S-41S
61. Rocca M., Colombo B., Falini A., et al. Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes. Lancet Neurol 4 (2005) 618-626
62. Stephan K., Harrison L., Kiebel S., David O., Penny W., and Friston K. Dynamic causal models of neural system dynamics:current state and future extensions. J Biosci 32 (2007) 129-144
63. Rocca M., Pagani E., Absinta M., et al. Altered functional and structural connectivities in patients with MS: a 3-T study. Neurology 69 (2007) 2136-2145
64. Rocca M., Valsasina P., Ceccarelli A., et al. Structural and functional MRI correlates of Stroop control in benign MS. Hum Brain Mapp (2007) 10.1002/hbm.20504 published online Nov 27.
65. Wegner C., Filippi M., Korteweg T., et al. Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol 15 (2008) 113-122
66. Youl B., Turano G., Miller D., et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 114 (1991) 2437-2450
67. Hickman S., Toosy A., Jones S., et al. Serial magnetization transfer imaging in acute optic neuritis. Brain 127 (2004) 692-700
68. Trip S., Wheeler-Kingshott C., Jones S., et al. Optic nerve diffusion tensor imaging in optic neuritis. NeuroImage 30 (2006) 498-505
69. Frohman E., Costello F., Zivadinov R., et al. Optical coherence tomography in multiple sclerosis. Lancet Neurol 5 (2006) 853-863
70. Lycklama a.N.G., Thompson A., Filippi M., et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol 2 (2003) 555-562
71. Agosta F., and Filippi M. MRI of spinal cord in multiple sclerosis. J Neuroimaging 1 (2007) 46S-49S
72. Agosta F., Valsasina P., Caputo D., Stroman P., and Filippi M. Tactile-associated recruitment of cervical cord is altered in patients with multiple sclerosis. NeuroImage 39 (2008) 1542-1548
73. Kendi A., Tan F., Kendi M., Yilmaz S., Huvaj S., and Tellioǧlu S. MR spectroscopy of cervical spinal cord in patients with multiple sclerosis. Neuroradiology 46 (2004) 764-769
74. Ciccarelli O., Wheeler-Kingshott C., McLean M., et al. Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 130 (2007) 2220-2231
75. Agosta F., Pagani E., Caputo D., and Filippi M. Associations between cervical cord gray matter damage and disability in patients with multiple sclerosis. Arch Neurol 64 (2007) 1302-1305
76. Whittall K., MacKay A., Graeb D., Nugent R., Li D., and Paty D. In vivo measurement of T2 distributions and water contents in normal human brain. Magn Reson Med 37 (1997) 34-43
77. Beaulieu C., Fenrich F., and Allen P. Multicomponent water proton transverse relaxation and T2-discriminated water diffusion in myelinated and nonmyelinated nerve. Magn Reson Imaging 16 (1998) 1201-1210
78. Moore G., Leung E., MacKay A., et al. A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain. Neurology 55 (2000) 1506-1510
79. Oh J., Han E., Lee M., Nelson S., and Pelletier D. Multislice brain myelin water fractions at 3T in multiple sclerosis. J Neuroimaging 17 (2007) 156-163
80. Laule C., Vavasour I., Moore G., et al. Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study. J Neurol 251 (2004) 284-293
81. Oh J., Han E., Pelletier D., and Nelson S. Measurement of in vivo multi-component T2 relaxation times for brain tissue using multi-slice T2 prep at 1·5 and 3 T. Magn Reson Imaging 24 (2006) 33-43
82. Laule C., Vavasour I., Kolind S., et al. Long T(2) water in multiple sclerosis: what else can we learn from multi-echo T(2) relaxation?. J Neurol 254 (2007) 1579-1587
83. Ge Y., Law M., Johnson G., et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol 26 (2005) 1539-1547
84. Ge Y., Law M., Inglese M., and Grossman R. Perfusion MRI. In: Filippi M., Rovaris M., and Comi G. (Eds). Neurodegeneration in multiple sclerosis (2007), Springer-Verlag, Milan 55-63
85. Adhya S., Johnson G., Herbert J., et al. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3·0 T. NeuroImage 33 (2006) 1029-1035
86. Wang J., Alsop D., Li L., et al. Comparison of quantitative perfusion imaging using arterial spin labeling at 1·5 and 4·0 Tesla. Magn Reson Med 48 (2002) 242-254
87. Sicotte N., Voskuhl R., Bouvier S., Klutch R., Cohen M., and Mazziotta J. Comparison of multiple sclerosis lesions at 1·5 and 3·0 Tesla. Invest Radiol 38 (2003) 423-427
88. Kangarlu A., Bourekas E., Ray-Chaudhury A., and Rammohan K. Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. AJNR Am J Neuroradiol 28 (2007) 262-266
89. Smith S., Farrell J., Jones C., Reich D., Calabresi P., and van Zijl P. Pulsed magnetization transfer imaging with body coil transmission at 3 Tesla: feasibility and application. Magn Reson Med 56 (2006) 866-875
90. Neema M., Stankiewicz J., Arora A., et al. T1 and T2 based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging 17 (2007) 16S-21S
91. Hammond K., Lupo J., Xu D., et al. Development of a robust method for generating 7·0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. NeuroImage 39 (2008) 1682-1692
92. Thulborn K., Davis D., Snyder J., Yonas H., and Kassam A. Sodium MR imaging of acute and subacute stroke for assessment of tissue viability. Neuroimaging Clin N Am 15 (2005) 639-653
93. Stankiewicz J., Panter S., Neema M., Arora A., Batt C., and Bakshi R. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 4 (2007) 371-386
94. Brass S., Benedict R., Weinstock-Guttman B., Munschauer F., and Bakshi R. Cognitive impairment is associated with subcortical MRI gray matter T2 hypointensity in multiple sclerosis. Mult Scler 12 (2006) 437-444
95. Zhang Y., Zabad R., Wei X., Metz L., Hill M., and Mitchell J. Deep gray matter "black T2" on 3 tesla magnetic resonance image correlates with disability in multiple sclerosis. Mult Scler 13 (2007) 880-883
96. Ge Y., Jensen J., Lu H., et al. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 28 (2007) 1639-1644
97. Vrenken H., Geurts J., Knol D., et al. Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology 240 (2006) 811-820
98. Tanenbaum L. Clinical 3T MR imaging: mastering the challenges. Magn Reson Imaging Clin N Am 14 (2006) 1-15